Codexis Inc reports results for the quarter ended in January - Earnings Summary

Codexis

02/05/2024 22:02

* Codexis Inc  CDXS.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -34
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 18 cents per share. Wall Street expected
results to range from -22 cents to -14 cents per share.
    * Revenue rose 31.5% to $17.07 million from a year ago;
analysts
expected $13.66 million. 
    * The company reported a quarterly loss of $11.51 million.
    * Codexis Inc shares had fallen by 10.9% this quarter and
gained 2.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Codexis Inc is
$5.00 
This summary was machine generated from LSEG data May 2 at 09:01
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.18          -0.16          Beat
 Dec. 31 2023      -0.12          -0.10          Beat
 Sep. 30 2023      -0.32          -0.50          Missed
 Jun. 30 2023      -0.21          -0.17          Beat